ROR1 and breast cancer: Besides, other molecules demonstrated in vitro and in vivo antitumor activity against BC, such as Natural killer group 2, member D (NKG2D) (72) or Receptor tyrosine kinase-like orphan receptor 1 (ROR1) (73).